These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 61506)

  • 41. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.
    Heymann MA; Rudolph AM; Silverman NH
    N Engl J Med; 1976 Sep; 295(10):530-3. PubMed ID: 950959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical treatment of ductus arteriosus.
    Ivey HH; Wells HH; Kattwinkel J
    Pediatrics; 1980 Apr; 65(4):863. PubMed ID: 7367106
    [No Abstract]   [Full Text] [Related]  

  • 43. Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
    Katayama Y; Minami H; Enomoto M; Takano T; Hayashi S; Lee YK
    J Perinatol; 2011 Jan; 31(1):21-4. PubMed ID: 20505743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histopathology of the ductus arteriosus after PGE1 treatment.
    Gittenberger-de Groot AC
    Pediatr Cardiol; 1995; 16(2):101. PubMed ID: 7784233
    [No Abstract]   [Full Text] [Related]  

  • 45. [Prostaglandin treatment of ductus-dependent congenital heart defects].
    Olsson B; Björkhem G; Lundström NR
    Lakartidningen; 1984 Oct; 81(40):3619-22. PubMed ID: 6541738
    [No Abstract]   [Full Text] [Related]  

  • 46. [Factors of motoricity of the ductus arteriosus].
    Messer J; de Geeter B
    Pediatrie; 1978 Dec; 33(8):811-8. PubMed ID: 569274
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 48. Maternal vitamin A administration and the fetal ductus arteriosus.
    Shaul PW
    Pediatr Res; 2001 Jun; 49(6):744-6. PubMed ID: 11385132
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical applications of prostaglandins and their inhibitors.
    Moskowitz MA; Coughlin SR
    Stroke; 1981; 12(6):882-6. PubMed ID: 7029794
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 51. The pharmacology of the ductus arteriosus.
    Smith GC
    Pharmacol Rev; 1998 Mar; 50(1):35-58. PubMed ID: 9549757
    [No Abstract]   [Full Text] [Related]  

  • 52. The effect of prostaglandin F2 alpha in the closure of the ductus arteriosus.
    Elliott RB; Starling MB
    Prostaglandins; 1972 Nov; 2(5):399-403. PubMed ID: 4631749
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: Prostaglandin E1 for interrupted aortic arch in the neonate.
    Radford DJ; Bloom KR; Coceani F; Fariello R; Olley PM
    Lancet; 1976 Jul; 2(7976):95. PubMed ID: 59171
    [No Abstract]   [Full Text] [Related]  

  • 54. The effects of caffeine on the preterm sheep ductus arteriosus.
    Clyman RI; Roman C
    Pediatr Res; 2007 Aug; 62(2):167-9. PubMed ID: 17597645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged prostaglandin E1 infusion: histologic effects on the patent ductus arteriosus.
    Cole RB; Abman S; Aziz KU; Bharati S; Lev M
    Pediatrics; 1981 Jun; 67(6):816-9. PubMed ID: 7232045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A preliminary report--heparin counteracts indomethacin effect on ductus arteriosus in very low birthweight infants.
    Ojala TH; Lehtonen L
    Pediatr Crit Care Med; 2007 May; 8(3):258-60. PubMed ID: 17496511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Path Toward Proactive Therapy for Patent Ductus Arteriosus.
    Yamada S; Terzic A
    Clin Pharmacol Ther; 2019 Dec; 106(6):1187-1190. PubMed ID: 31433488
    [No Abstract]   [Full Text] [Related]  

  • 59. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    Clyman RI; Brett C; Mauray F
    Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Derivatives of arachidonic acid. II. Medical perspectives].
    Anker R; Quezada A
    Bol Med Hosp Infant Mex; 1986 May; 43(5):316-22. PubMed ID: 3524602
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.